Exelon (NASDAQ:EXC - Get Free Report) will likely be releasing its Q2 2025 earnings data before the market opens on Thursday, July 31st. Analysts expect the company to announce earnings of $0.46 per share and revenue of $5.47 billion for the quarter. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS.
Exelon (NASDAQ:EXC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.86 by $0.06. The firm had revenue of $6.71 billion during the quarter, compared to analyst estimates of $6.30 billion. Exelon had a return on equity of 10.29% and a net margin of 11.44%. The business's quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.68 earnings per share. On average, analysts expect Exelon to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Exelon Trading Up 0.6%
Exelon stock traded up $0.25 during trading on Friday, hitting $43.99. The company's stock had a trading volume of 3,894,398 shares, compared to its average volume of 7,472,804. The stock has a market capitalization of $44.41 billion, a price-to-earnings ratio of 16.35, a P/E/G ratio of 2.55 and a beta of 0.39. The stock's fifty day moving average is $43.26 and its 200 day moving average is $43.30. Exelon has a 1-year low of $35.94 and a 1-year high of $48.11. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.98 and a current ratio of 1.09.
Exelon Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Monday, May 12th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 3.64%. The ex-dividend date was Monday, May 12th. Exelon's dividend payout ratio (DPR) is 59.48%.
Analyst Upgrades and Downgrades
EXC has been the subject of a number of research analyst reports. BMO Capital Markets upped their price objective on Exelon from $46.00 to $50.00 and gave the stock an "outperform" rating in a report on Monday, April 28th. UBS Group restated a "neutral" rating and set a $48.00 price target (up from $47.00) on shares of Exelon in a research note on Friday, July 11th. KeyCorp dropped their target price on shares of Exelon from $39.00 to $37.00 and set an "underweight" rating for the company in a research report on Wednesday, July 16th. Guggenheim increased their target price on shares of Exelon from $47.00 to $50.00 and gave the stock a "buy" rating in a research report on Friday, May 2nd. Finally, Morgan Stanley dropped their price objective on shares of Exelon from $49.00 to $48.00 and set an "equal weight" rating for the company in a research report on Thursday, May 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $47.20.
Get Our Latest Stock Report on EXC
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Exelon stock. Caxton Associates LLP bought a new stake in shares of Exelon Corporation (NASDAQ:EXC - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 6,199 shares of the company's stock, valued at approximately $286,000. Institutional investors own 80.92% of the company's stock.
Exelon Company Profile
(
Get Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Recommended Stories

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.